We are live on ! Find out more
SGNT

SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT

Delisted

SGNT was delisted on the 29th of August, 2016.

131 hedge funds and large institutions have $614M invested in SAGENT PHARMACEUTICALS INC COM STK (DE) in 2014 Q4 according to their latest regulatory filings, with 30 funds opening new positions, 57 increasing their positions, 30 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 30 | Existing positions closed: 10

90% more repeat investments, than reductions

Existing positions increased: 57 | Existing positions reduced: 30

15% more funds holding

Funds holding: 114131 (+17)

16% less capital invested

Capital invested by funds: $734M → $614M (-$119M)

100% less call options, than puts

Call options by funds: $4K | Put options by funds: $1.26M

Holders
131
Holders Change
+17
Holders Change %
+14.91%
% of All Funds
3.49%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
30
Increased
57
Reduced
30
Closed
10
Calls
$4K
Puts
$1.26M
Net Calls
-$1.25M
Net Calls Change
-$1.25M
Name Holding Trade Value Shares
Change
Change in
Stake
TPSF
76
Texas Permanent School Fund
Texas
$512K -$4.14K -141 -0.7%
Swiss National Bank
77
Swiss National Bank
Switzerland
$512K
WMSA
78
Weiss Multi-Strategy Advisers
New York
$502K -$147K -5,000 -20%
GAM
79
Gotham Asset Management
New York
$499K +$383K +13,064 +191%
Bank of America
80
Bank of America
North Carolina
$489K +$478K +16,288 +512%
SCA
81
Secor Capital Advisors
New York
$473K +$553K +18,834 New
State of Tennessee, Department of Treasury
82
State of Tennessee, Department of Treasury
Tennessee
$444K +$519K +17,700 New
DekaBank Deutsche Girozentrale
83
DekaBank Deutsche Girozentrale
Germany
$437K -$46.9K -1,600 -9%
MLICM
84
Metropolitan Life Insurance Company (MetLife)
New York
$434K
Renaissance Technologies
85
Renaissance Technologies
New York
$427K +$499K +17,000 New
BIM
86
Bogle Investment Management
Massachusetts
$421K -$1.22M -41,710 -71%
NFA
87
Nationwide Fund Advisors
Ohio
$421K -$1.7K -58 -0.3%
AIG
88
American International Group
New York
$412K -$14.3K -489 -3%
ASRS
89
Arizona State Retirement System
Arizona
$396K +$2.93K +100 +0.6%
Bank of Montreal
90
Bank of Montreal
Ontario, Canada
$361K +$53.1K +1,809 +14%
VOYA Investment Management
91
VOYA Investment Management
Georgia
$357K
PCM
92
Piermont Capital Management
Missouri
$356K +$416K +14,170 New
AQR Capital Management
93
AQR Capital Management
Connecticut
$326K +$381K +13,000 New
CSS
94
Cubist Systematic Strategies
Connecticut
$323K +$377K +12,852 New
JG
95
Jefferies Group
New York
$303K +$354K +12,077 New
SG Americas Securities
96
SG Americas Securities
New York
$300K +$350K +11,934 New
Citigroup
97
Citigroup
New York
$292K +$10.3K +352 +3%
LSERS
98
Louisiana State Employees Retirement System
Louisiana
$264K +$2.93K +100 +1%
State Board of Administration of Florida Retirement System
99
State Board of Administration of Florida Retirement System
Florida
$257K
Nomura Holdings
100
Nomura Holdings
Japan
$251K +$296K +10,077 New

SGNT Hedge Fund Activity: Q4 2014 in Review

131 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) for Q4 2014, worth a combined $614M — down 16% from $734M a quarter earlier.

Buyers outnumbered sellers: 30 funds opened new SGNT positions and 10 closed out — a net gain of 20 holders — while 57 added to existing stakes and 30 trimmed.

The largest buyer was Acadian Asset Management, adding an estimated $19.4M. The largest seller was Franklin Resources, cutting an estimated $37.4M.

  • 131 institutional investors held SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) as of Q4 2014, up from 114 in Q3 2014.
  • Funds reported $614M of SAGENT PHARMACEUTICALS INC COM STK (DE) stock for Q4 2014, down 16% quarter-over-quarter.
  • 30 funds opened new SAGENT PHARMACEUTICALS INC COM STK (DE) positions in Q4 2014 and 10 closed out, a net change of +20 holders.
  • The largest SAGENT PHARMACEUTICALS INC COM STK (DE) buyer in Q4 2014 was Acadian Asset Management, an estimated $19.4M added.
  • The largest SAGENT PHARMACEUTICALS INC COM STK (DE) seller in Q4 2014 was Franklin Resources, an estimated $37.4M sold.

Based on aggregated 13F filings for Q4 2014.